Granulocyte Colony-Stimulating Factors (G-CSFs) for Hematopoietic ARS

Type: drug

Status: FDA Approved

Developer: Amgen (Neupogen, Neulasta), Sanofi (Leukine)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026